Search - tctmd.com

Displaying 961 - 980 of 1598

Sort: Relevancy | Date

News Daily News

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Yael L. Maxwell

December 22, 2015

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Yael L. Maxwell

December 22, 2015

Presentation

Outcomes of Patients With Acute MI Undergoing PCI Receiving an Oral Anticoagulant and DAPT

Presenter: Larry R. Jackson

December 21, 2015

Presentation

Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy

Presenter: MB. Kadakia

December 20, 2015

News Daily News

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Caitlin E. Cox

December 20, 2015

News Daily News

心梗后、PCI 后以及 CAD 患者的他汀类药物绩效指标发生修订

Michael O'Riordan

December 20, 2015

News Daily News

Revisión de las Métricas de Rendimiento para el Uso de Estatinas Post-IM, Post-PCI en Pacientes EAC

Michael O'Riordan

December 20, 2015

News Daily News

Radial-Access Associated with One-Third Less Bleeding in Rescue PCI After Fibrinolysis

Michael O'Riordan

December 20, 2015

News Daily News

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Performance Metrics Revised for Statins Post-MI, After PCI, and in CAD Patients

Michael O'Riordan

December 20, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

Presentation

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

Presenter: PA. Gurbel

December 16, 2015

News Daily News

依泽替米贝减少心血管事件的说法未能获得 FDA 顾问委员会的支持

Michael O'Riordan

December 15, 2015

News Daily News

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Michael O'Riordan

December 15, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

Un Subestudio del CvLPRIT Halla Pequeños Daños Pasajeros en PCI de Arterias No Infartada

Caitlin E. Cox

December 15, 2015

News Daily News

研究表明 PCI 进展会削弱比伐卢定在出血风险方面的优势

Todd Neale

December 14, 2015

News Daily News

研究肯定了 Watchman 左心耳封堵器减少卒中的成本效益

L.A. McKeown

December 14, 2015

News Daily News

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

L.A. McKeown

December 14, 2015

Advertisement

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Outcomes of Patients With Acute MI Undergoing PCI Receiving an Oral Anticoagulant and DAPT

Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

心梗后、PCI 后以及 CAD 患者的他汀类药物绩效指标发生修订

Revisión de las Métricas de Rendimiento para el Uso de Estatinas Post-IM, Post-PCI en Pacientes EAC

Radial-Access Associated with One-Third Less Bleeding in Rescue PCI After Fibrinolysis

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Performance Metrics Revised for Statins Post-MI, After PCI, and in CAD Patients

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

依泽替米贝减少心血管事件的说法未能获得 FDA 顾问委员会的支持

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Un Subestudio del CvLPRIT Halla Pequeños Daños Pasajeros en PCI de Arterias No Infartada

研究表明 PCI 进展会削弱比伐卢定在出血风险方面的优势

研究肯定了 Watchman 左心耳封堵器减少卒中的成本效益

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content